ARIAD’s $5.2 Billion Merger with Takeda

Simpson Thacher is representing J.P. Morgan Securities LLC as financial advisor to ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) in connection with its definitive agreement to be acquired…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here